Chembio Diagnostics (CEMI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2009 | 12-2008 | 09-2008 | 06-2008 | 03-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,292 | 1,212 | 999 | 954 | 1,765 |
| Receivables | 622 | 809 | 2,021 | 1,435 | 953 |
| Inventories | 1,680 | 1,819 | 1,192 | 1,449 | 1,506 |
| TOTAL | $3,832 | $4,066 | $4,469 | $4,150 | $4,538 |
| Non-Current Assets | |||||
| PPE Net | 783 | 881 | 954 | 965 | 933 |
| Intangibles | 902 | 940 | 1,035 | 1,076 | 1,116 |
| Other Non-Current Assets | 180 | 28 | 28 | 28 | 28 |
| TOTAL | $1,865 | $1,849 | $2,017 | $2,069 | $2,077 |
| Total Assets | $5,697 | $5,915 | $6,486 | $6,219 | $6,615 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,111 | 2,383 | 2,694 | 2,205 | 2,367 |
| TOTAL | $2,498 | $2,402 | $2,812 | $2,324 | $2,416 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 368 | N/A | 100 | 100 | 31 |
| Other Non-Current Liabilities | 875 | 875 | 500 | 500 | 500 |
| TOTAL | $931 | $936 | $566 | $571 | $575 |
| Total Liabilities | $3,429 | $3,338 | $3,378 | $2,894 | $2,992 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,743 | 7,743 | 7,743 | 7,743 | 7,567 |
| Common Shares | 619 | 619 | 619 | 619 | 605 |
| Retained earnings | -37,620 | -37,295 | -36,744 | -36,507 | -36,144 |
| TOTAL | $2,268 | $2,577 | $3,108 | $3,325 | $3,624 |
| Total Liabilities And Equity | $5,697 | $5,915 | $6,486 | $6,219 | $6,615 |